Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.7 |
mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |